These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6364447

  • 21. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H, Rość D, Chyzy R, Bodzenta A, Szpak A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
    [Abstract] [Full Text] [Related]

  • 22. [Hemostatic state in arteriosclerosis obliterans of the arteries of the lower extremities].
    Kurguzov OP, Iakunin GA, Smolianitskiĭ AIa, Lavrova LA, Shumbalina LF.
    Ter Arkh; 1982; 54(6):128-33. PubMed ID: 7112412
    [No Abstract] [Full Text] [Related]

  • 23. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M, Bodzenta A, Lukjan H, Kiersnowska-Rogowska B, Kłoczko J, Myśliwiec M, Dabrowski S, Tymiński W, Czestochowska E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [Abstract] [Full Text] [Related]

  • 24. [Use of nitrendipine in treating patients with obliterative atherosclerosis of arteries in the lower extremities].
    Grodzińska L, Kostka-Trabka E, Basista M, Bieroń K, Sławiński M, Telesz E.
    Pol Tyg Lek; 1986; 46(32-34):598-600. PubMed ID: 1669121
    [Abstract] [Full Text] [Related]

  • 25. [The potentials of laser and electromagnetic-laser therapy in the treatment of patients with arteriosclerosis obliterans of the vessels of the lower extremities].
    Galimzianov FV.
    Vestn Khir Im I I Grek; 1996; 155(5):37-9. PubMed ID: 9123753
    [Abstract] [Full Text] [Related]

  • 26. [Supravascular laser exposure in combined modality treatment of patients with arteriosclerosis obliterans of blood vessels of lower extremities].
    Leont'eva NV, Evdokimova TA, Sedletskaia EIu, Dmitrieva IaV, Zolotnitskaia VP.
    Vopr Kurortol Fizioter Lech Fiz Kult; 2001; (3):5-7. PubMed ID: 11550389
    [Abstract] [Full Text] [Related]

  • 27. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S, Cailleux N, Lévesque H.
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [Abstract] [Full Text] [Related]

  • 28. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y, Ohmori T, Hoshide S, Madoiwa S, Yamamoto K, Katsuki T, Mitsuhashi T, Mimuro J, Shimada K, Kario K, Sakata Y.
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
    Okuro M, Morimoto S, Takahashi T, Okaishi K, Nakahashi T, Murai H, Iwai K, Kanda T, Matsumoto M.
    Hypertens Res; 2006 Sep; 29(9):655-63. PubMed ID: 17249520
    [Abstract] [Full Text] [Related]

  • 30. [The effect of treatment with sulphur water from the spring in Wiesław in Busko-Solec on levels of lipids,the fibrinolytic system and thrombogenic platelet function in patients with arteriosclerosis].
    Goszcz A, Kostka-Trabka E, Grodzińska L, Sławiński M, Bieroń K, Jachym R, Kucharski K, Gryglewski RJ.
    Pol Merkur Lekarski; 1997 Jul; 3(13):33-6. PubMed ID: 9432299
    [Abstract] [Full Text] [Related]

  • 31. [Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].
    Szczeklik A, Głusko P, Gryglewski R, Szczeklik J, Kostka-Trabka E, Grodzińska L, Nizanowski R, Dembińska-Kieć A, Skawiński S, Bieroń K, Billewicz O, Telesz E.
    Przegl Lek; 1980 Jul; 37(9):659-62. PubMed ID: 6106960
    [No Abstract] [Full Text] [Related]

  • 32. Misoprostol as agonist of IP2 receptor.
    Goszcz A, Bierón K, Grodzińska L.
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):635-41. PubMed ID: 12512698
    [Abstract] [Full Text] [Related]

  • 33. [Therapeutic use of prostacyclin in cardiovascular pathology].
    Martelli M, Nicolosi G.
    Minerva Med; 1983 Nov 16; 74(44):2665-70. PubMed ID: 6419178
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG, Potapov VV, Ogneva NS, Zybina NN.
    Vestn Khir Im I I Grek; 1994 Nov 16; 152(1-2):30-4. PubMed ID: 7701736
    [Abstract] [Full Text] [Related]

  • 36. [Conservative treatment of arteriosclerosis obliterans of the lower limbs].
    Kancelarczyk WL, Rymaszewski Z.
    Kardiol Pol; 1981 Nov 16; 24(8):571-7. PubMed ID: 6169868
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
    Davì G, Pinto A, Novo S, Avellone G, Galati D, Mazzola A.
    Clin Ter; 1982 Oct 31; 103(2):131-7. PubMed ID: 6295693
    [No Abstract] [Full Text] [Related]

  • 39. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans].
    Hess H, Goossens N, Keil-Kuri E, Zollner R, Meyer A.
    Vasa; 1972 Oct 31; 1(3):206-11. PubMed ID: 5076123
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.